A recent meta-analysis investigating the biomarkers that correlated with treatment response in active PTB by calculating fold change in unstimulated plasma levels identified CRP, IL-6, IP-10, and TNF-α as important in monitoring TB treatment and recommended that these should be explored in future studies24. The gene discussed is IL6; the disease is tuberculosis.